Results 21 to 30 of about 10,082 (205)
Pharmacokinetics of Faster and Standard Insulin Aspart During Fully Closed-Loop Insulin Delivery in Type 2 Diabetes. [PDF]
, 2020 Background: Faster insulin aspart is a novel formulation of insulin aspart aiming to accelerate its subcutaneous absorption. The aim of this study was to compare pharmacokinetics of faster insulin aspart versus standard insulin aspart in adults with type
Nakas, Christos T. +6 more
core +4 more sources
Short‐term fully closed‐loop insulin delivery using faster insulin aspart compared to standard insulin aspart in type 2 diabetes [PDF]
, 2019 We evaluated the efficacy and safety of short‐term fully closed‐loop insulin delivery using faster versus standard insulin aspart in type 2 diabetes. Fifteen adults with insulin‐treated type 2 diabetes underwent 22 hours of closed‐loop insulin delivery ...
Hovorka, Roman +19 more
core +4 more sources
Anales de Pediatría (English Edition), 2021 Background and aims: Post-prandial glucose control is essential to achieve metabolic goals in patients with type 1 diabetes mellitus (T1DM). The new “faster aspart” insulin has a pharmacological profile noted for its faster absorption and onset of action,
Jesús González de Buitrago Amigo +6 more
doaj +1 more source
Anales de Pediatría, 2021 Resumen: Introducción y objetivos: El control glucémico postprandial es fundamental para conseguir los objetivos metabólicos en pacientes con diabetes mellitus tipo 1 (DM1).
Jesús González de Buitrago Amigo +6 more
doaj +1 more source
Safety, Tolerability, and Efficacy of Insulin Aspart in People with Type 2 Diabetes, as Biphasic Insulin Aspart or with Basal Insulin: Findings from the Multinational, Non-Interventional A1chieve Study [PDF]
, 2014 \ua9 2014, The Author(s).Conclusion: Insulin aspart therapy was well tolerated and was associated with improved glucose control over 24 weeks in people with T2DM.Methods: Insulin-na\uefve and insulin-experienced people with T2DM in routine clinical care ...
Hajjaji I +5 more
core +4 more sources
Indian Journal of Endocrinology and Metabolism, 2015 As injectable therapies such as human insulin, insulin analogs, and glucagon-like peptide-1 receptor agonists are used to manage diabetes, correct injection technique is vital for the achievement of glycemic control.
Nikhil Tandon +17 more
doaj +1 more source
Indian Journal of Endocrinology and Metabolism, 2013 Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Issam M Hajjaji +5 more
doaj +1 more source
Effect of fully automated closed-loop insulin delivery using faster aspart versus standard aspart on gluco-regulatory hormones in type 2 diabetes. [PDF]
, 2020 We retrospectively assessed gluco-regulatory hormones over 10 h (including two meals) of fully automated closed-loop insulin delivery using faster (FA) versus standard insulin aspart (IAsp) in adults with type 2 diabetes [n = 15, age 59 ± 10 years, body ...
Kuenzli, Christina +13 more
core +2 more sources
Journal of the Formosan Medical Association, 2019 Although hypersensitivity reaction to insulin was supposed to be less-frequent with current insulin analogue, case reports with different types of allergic reactions to insulin analogue were still reported. The most common form is type I hypersensitivity
Wei-Lun Wen +6 more
doaj +1 more source
Lipoatrofia związana z podażą szybko działających analogów insuliny u młodych pacjentów chorujących na cukrzycę typu 1 [PDF]
Pediatric Endocrinology, Diabetes and Metabolism, 2008 Lipoatrofia, jako skórne powikłanie występujące u chorych na cukrzycę, przestała być problemem klinicznym po wprowadzeniu do leczenia ludzkiej insuliny.
Agata Skórka +2 more
doaj